Ö. MEHTAP Et Al. , "IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.," Journal of postgraduate medicine , vol.60, no.2, pp.141-4, 2014
MEHTAP, Ö. Et Al. 2014. IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.. Journal of postgraduate medicine , vol.60, no.2 , 141-4.
MEHTAP, Ö., Atesoglu, E. B., TARKUN, P., Hacihanefioglu, A., DOLAŞIK, İ., & Musul, M. M., (2014). IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.. Journal of postgraduate medicine , vol.60, no.2, 141-4.
MEHTAP, ÖZGE Et Al. "IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.," Journal of postgraduate medicine , vol.60, no.2, 141-4, 2014
MEHTAP, ÖZGE Et Al. "IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.." Journal of postgraduate medicine , vol.60, no.2, pp.141-4, 2014
MEHTAP, Ö. Et Al. (2014) . "IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.." Journal of postgraduate medicine , vol.60, no.2, pp.141-4.
@article{article, author={ÖZGE MEHTAP Et Al. }, title={IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.}, journal={Journal of postgraduate medicine}, year=2014, pages={141-4} }